Qualio Secures $50 Million in Series B Funding To Help Innovative Life Sciences Companies Unite Speed with Quality

This latest round of funding will support Qualios efforts to expand accessibility of their electronic quality management software (eQMS) and services for life sciences customers at global scale and also fuel significant investment in product and engineering team growth. As modern life sciences companies look to accelerate industry innovation and disruption, they cannot afford to have inefficient quality management slow down product accessibility. "Modern-day life sciences companies need state-of-the art, easy-to-use tools to address what consumers have come to expect — to be able to trust that the products we put in or on our bodies are safe and effective and will work consistently to improve health and well-being." "Qualio has proven its ability to support life sciences organizations in bringing life-saving products to market faster without jeopardizing quality," said John Curtius, Partner, Tiger Global. Leading pharmaceutical, biotech, medical device, and clinical research organizations leverage Qualios cloud-based quality management system software to unite their teams processes and data.